Webinars Post

Welcome to the new marketing jungle

Too long we’ve spent in the digital wilderness – tweaking aging processes, fiddling at the edges, and hitting our heads against digital and compliance...

Admin - April 23, 2021

Webinars Post

The path to market for digital health solutions

Pharma's approach to digital healthcare products is maturing. The era of experimental pilot apps is being replaced with a more sophisticated and strategic approach....

Admin - April 23, 2021

Webinars Post

BMS, GSK and Astellas join OKRA to discuss the answer to uncertainty

We live in an increasingly digital world. Even more so following Covid-19. As our field forces transition to an online/hybrid model, we start to think...

Admin - April 23, 2021

Webinars Post

Digital companions – the future of holistic patient support

Adherence can no longer be the solitary focus of patient support. If we want treatment it be successful, it is our duty to care...

Admin - April 22, 2021

Webinars Post

5 changes you have to make right now: Accelerating HCP engagement post-crisis

Eight in ten doctors anticipate a permanent increase in virtual or remote interactions with sales representatives. To stay ahead of the competition, we need...

Admin - April 22, 2021

Webinars Post

Patient engagement in Covid-19

Patient engagement and PSP creation have, like many things, been turned upside down in this pandemic. And while it may be easier to reach...

Admin - April 22, 2021

12 3...5 Page 1 of 5

IGC Completes the Final Cohort of Its Phase 1 Clinical Trial on Alzheimer’s Patients

Industry News June 24, 2021

FDA Accepts Application for Genentech’s Port Delivery System With Ranibizumab (PDS) for Treatment of Wet Age-Related Macular Degeneration (AMD)

Regulatory Affairs June 24, 2021

Mercy Ships International Board Announces the Appointment of Gert van de Weerdhof as Interim CEO as Current CEO Tom Stogner retires

Look Who’s On the Move! June 24, 2021

Ray Pawlicki, Previously CIO at Biogen and Novartis, Joins PrecisionLife as Executive Chair to Accelerate Strategic Expansion

Editor´s Pick June 24, 2021

NanoTemper Enters Protein Production Market With Andromeda, Helping Biopharma and CROs to Increase Efficiency of Expression Screening for Membrane Proteins

Industry News June 24, 2021

LYNPARZA® (olaparib) Approved in China for the Treatment of Certain Patients with BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

Regulatory Affairs June 24, 2021

Alnylam Announces U.S. Food and Drug Administration Acceptance of New Drug Application for Investigational Vutrisiran for the Treatment of the Polyneuropathy of Hereditary ATTR...

Regulatory Affairs June 24, 2021

EQRx and Exscientia Enter Strategic Drug Creation, Development, and Commercialization Collaboration to Accelerate the Advancement of New World-Class Medicines

Industry News June 24, 2021

Foundation Medicine Collaborates on Research Published in The New England Journal of Medicine That Identifies Resistance to KRAS Inhibitors and Underscores Need for Novel...

Industry News June 24, 2021

Carmot Therapeutics Initiates the Clinical Program for CT-388, a Dual GLP-1 and GIP Receptor Modulator for the Treatment of Patients with Type 2 Diabetes...

Industry News June 24, 2021

New Science 37® Report: Nearly 100% of Biopharma Executives Expect Clinical Trial Decentralization to Increase Yet Lack Internal Capabilities to Operationalize

Industry News June 24, 2021

IM Therapeutics Co-Founder and CMO Peter Gottlieb, M.D, to Present Advances in Genetically Targeted Therapies for Type 1 Diabetes at the 2021 ADA Scientific...

Industry News June 24, 2021

Webinars Post

Recent Articles

IGC Completes the Final Cohort of Its Phase 1 Clinical Trial on Alzheimer’s Patients

FDA Accepts Application for Genentech’s Port Delivery System With Ranibizumab (PDS) for Treatment of Wet Age-Related Macular Degeneration (AMD)

Mercy Ships International Board Announces the Appointment of Gert van de Weerdhof as Interim CEO as Current CEO Tom Stogner retires

Ray Pawlicki, Previously CIO at Biogen and Novartis, Joins PrecisionLife as Executive Chair to Accelerate Strategic Expansion

NanoTemper Enters Protein Production Market With Andromeda, Helping Biopharma and CROs to Increase Efficiency of Expression Screening for Membrane Proteins

LYNPARZA® (olaparib) Approved in China for the Treatment of Certain Patients with BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

Verastem Oncology Appoints Paul Bunn, M.D., and Lesley Solomon to Board of Directors

Cybin Announces Former FDA Psychiatry Division Director Dr. Thomas Laughren has Joined Clinical Advisory Board

Catamaran Bio and Bio-Techne Announce Expanded Collaboration for CAR‑NK Cell Manufacturing Technologies

Alnylam Announces U.S. Food and Drug Administration Acceptance of New Drug Application for Investigational Vutrisiran for the Treatment of the Polyneuropathy of Hereditary ATTR...

EQRx and Exscientia Enter Strategic Drug Creation, Development, and Commercialization Collaboration to Accelerate the Advancement of New World-Class Medicines

Foundation Medicine Collaborates on Research Published in The New England Journal of Medicine That Identifies Resistance to KRAS Inhibitors and Underscores Need for Novel...

Carmot Therapeutics Initiates the Clinical Program for CT-388, a Dual GLP-1 and GIP Receptor Modulator for the Treatment of Patients with Type 2 Diabetes...

New Science 37® Report: Nearly 100% of Biopharma Executives Expect Clinical Trial Decentralization to Increase Yet Lack Internal Capabilities to Operationalize

IM Therapeutics Co-Founder and CMO Peter Gottlieb, M.D, to Present Advances in Genetically Targeted Therapies for Type 1 Diabetes at the 2021 ADA Scientific...